Pneumocystis jirovecii (Pneumocystis pneumonia)
3,319views
Assessments
Flashcards
0 / 36 complete
USMLE® Step 1 questions
0 / 3 complete
Flashcards
Pneumocystis jirovecii (Pneumocystis pneumonia)
0 of 36 complete
Questions
USMLE® Step 1 style questions USMLE
0 of 3 complete
Radiopedia
External References
First Aid
2024
2023
2022
2021
Pneumocystis jirovecii p. , 151
dapsone p. 191
HIV-positive adults p. 174
immunocompromised patients p. 176
silver stain for p. 123
TMP-SMX p. 191
AIDS (acquired immunodeficiency syndrome)
Pneumocystis jirovecii p. , 151
Atovaquone
for Pneumocystis jirovecii p. , 151
Dapsone p. 191
Pneumocystis jirovecii p. , 151
HIV (human immunodeficiency virus) p. 173
Pneumocystis jirovecii p. , 151
Immunocompromised patients
Pneumocystis jirovecii p. , 151
Pneumonia p. 701
Pneumocystis jirovecii p. , 151
TMP-SMX p. 191
for Pneumocystis jirovecii p. , 151
Pneumocystis spp. p. 115
Pneumocystis pneumonia
HIV-positive adults p. 174
prophylaxis p. 194
Summary
Pneumocystis jirovecii sometimes referred to as Pneumocystis carinii, is a fungus known to cause a severe lung infection called Pneumocystis pneumonia (PCP). PCP commonly affects individuals with weakened immune systems, such as people with HIV/AIDS, cancer patients receiving chemotherapy, or people taking immunosuppressive drugs. Symptoms of PCP can include fever, cough, shortness of breath, and difficulty breathing. Treatment typically involves antifungal medications, such as trimethoprim-sulfamethoxazole, pentamidine, or dapsone.